Morphological Macular Changes Under Brolucizumab Treatment for Neovascular Age-Related Macular Degeneration Refractory to Previous Anti-VEGF Treatment Compared with Treatment-Naive Eyes

Morphological Macular Changes Under Brolucizumab Treatment for Neovascular Age-Related Macular Degeneration Refractory to Previous Anti-VEGF Treatment Compared with Treatment-Naive Eyes

Antony William, Raoul Verma-Fuehring, Sophia Kuehnel, Dorothee Schwabe, Daniel Kampik, Winfried Goebel, Jost Hillenkamp Department of Ophthalmology, University Hospital Würzburg, Würzburg, GermanyCorrespondence: Antony William, Department of Ophthalmology, University Hospital Würzburg, Joseph–Schnei...

Full description

Bibliographic Details
Main Authors: William A, Verma-Fuehring R, Kuehnel S, Schwabe D, Kampik D, Goebel W, Hillenkamp J
Format: Article
Language:English
Published: Dove Medical Press 2023-03-01
Series:Clinical Ophthalmology
Subjects:
treatment naive (tn) and refractory treatment (rt).
Online Access:https://www.dovepress.com/morphological-macular-changes-under-brolucizumab-treatment-for-neovasc-peer-reviewed-fulltext-article-OPTH

Internet

https://www.dovepress.com/morphological-macular-changes-under-brolucizumab-treatment-for-neovasc-peer-reviewed-fulltext-article-OPTH

Similar Items